Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 11Delirium 3Central Nervous System Diseases 2Supratentorial Neoplasms 1Spinal Cord Neoplasms 1Pain 1Neuroinflammatory Diseases 1Neurofibromatoses 1Neurocognitive Disorders 1Neoplasms 1Meningioma 1Intracranial Aneurysm 1Hypoxia 1Hydrocephalus 1Headache 1Epilepsy 1Emergence Delirium 1Cerebrovascular Disorders 1Abdominal Neoplasms 1

Interventions

Magnetoencephalography 1Magnetic Resonance Imaging 1Fluorescein 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cerebrovascular Disorders × Dexmedetomidine × CNS × Clear all
NCT02878707 2020-09-22

The Neuroprotective Effects of Dexmedetomidine During Brain Surgery

National Taiwan University Hospital

Phase NA Completed
160 enrolled
CNS

Brain Neoplasms, Cerebrovascular Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡